ATOSSA THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
ATOSSA THERAPEUTICS, INC. (ATOS) reported Increase (Decrease) in Prepaid Expense and Other Assets of $665.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$34.00K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $699.00K, a 155.11% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $548.00K, a 154.88% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$495.00K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$37.00K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$997.00K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.00M.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$180.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $665.00K 10-Q · filed 2026-08-07 | $1.21M derived: sum of 3 quarters · filed 2026-08-07 | $718.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $699.00K 10-Q · filed 2026-05-08 | $1.25M derived: sum of 2 quarters · filed 2026-05-08 | $752.00K derived: sum of 3 quarters · filed 2026-05-08 | $388.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $53.00K derived: sum of 2 quarters · filed 2026-03-25 | -$311.00K derived: sum of 3 quarters · filed 2026-08-07 | -$37.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | -$495.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$859.00K derived: sum of 2 quarters · filed 2026-08-07 | -$585.00K 10-Q · filed 2025-11-12 | -$370.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | -$364.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$90.00K 10-Q · filed 2026-08-07 | $125.00K derived: sum of 3 quarters · filed 2026-08-07 | $88.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $274.00K 10-Q · filed 2026-05-08 | $489.00K derived: sum of 2 quarters · filed 2026-05-08 | $452.00K derived: sum of 3 quarters · filed 2026-05-08 | -$174.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $178.00K derived: sum of 2 quarters · filed 2026-03-25 | -$448.00K derived: sum of 3 quarters · filed 2026-03-25 | -$997.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$663.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.21M 10-Q · filed 2025-11-12 | -$1.67M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$626.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.18M 10-Q · filed 2025-08-12 | -$1.64M derived: sum of 3 quarters · filed 2025-08-12 | -$2.27M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$549.00K 10-Q · filed 2025-05-13 | -$1.01M derived: sum of 2 quarters · filed 2025-05-13 | -$1.64M derived: sum of 3 quarters · filed 2025-05-13 | -$1.66M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$1.09M derived: sum of 2 quarters · filed 2025-03-25 | -$1.11M derived: sum of 3 quarters · filed 2025-03-25 | -$1.00M 10-K · filed 2025-03-25 | -$261.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | -$633.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$650.00K derived: sum of 2 quarters · filed 2024-11-12 | -$542.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $91.00K 10-Q · filed 2024-08-12 | |||
| 2023-03-31 | $108.00K 10-Q · filed 2024-05-13 | ||||
| 2022-12-31 | -$180.00K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |